Authors: Pellegrin, I Garrigue, I Caumont, A Pellegrin, JL Merel, P Schrive, MH Bonot, P Fleury, H

Citation: I. Pellegrin et al., Persistence of zidovudine-resistance mutations in HIV-1 isolates from patients removed from zidovudine therapy for at least 3 years and switched to astavudine-containing regimen, AIDS, 15(8), 2001, pp. 1071-1073

Authors: Merel, P Pellegrin, I Garrigue, I Caumont, A Schrive, MH Birac, V Bonot, P Fleury, H

Citation: P. Merel et al., Comparison of capillary electrophoresis sequencing with the new CEQ 2000 DNA Analysis System to conventional gel based systems for HIV drug resistance analysis, J VIROL MET, 98(1), 2001, pp. 9-16

Authors: Pellegrin, I Segondy, M Garrigue, I Izopet, J Montes, B Pellegrin, JL Reynes, J Massip, P Puel, J Fleury, H

Citation: I. Pellegrin et al., Phenotypic resistance pattern of HIV-1 isolates with zidovudine and/or multidrug resistance mutations after didanosine-stavudine combination therapy, J ACQ IMM D, 25(5), 2000, pp. 465-466

Authors: Garrigue, I Pellegrin, I Hoen, B Dumon, B Harzic, M Schrive, MH Sereni, D Fleury, H

Citation: I. Garrigue et al., Cell-associated HIV-1-DNA quantitation after highly active antiretroviral therapy-treated primary infection in patients with persistently undetectable plasma HIV-1 RNA, AIDS, 14(18), 2000, pp. 2851-2855

Authors: Pellegrin, I Garrigue, I Ekouevi, D Couzi, L Merville, P Merel, P Chene, G Schrive, MH Trimoulet, P Lafon, ME Fleury, H

Citation: I. Pellegrin et al., New molecular assays to predict occurrence of cytomegalovirus disease in renal transplant recipients, J INFEC DIS, 182(1), 2000, pp. 36-42

Authors: Pellegrin, I Garrigue, I Binquet, C Chene, G Neau, D Bonot, P Bonnet, F Fleury, W Pellegrin, JL

Citation: I. Pellegrin et al., Evaluation of new quantitative assays for diagnosis and monitoring of cytomegalovirus disease in human immunodeficiency virus-positive patients, J CLIN MICR, 37(10), 1999, pp. 3124-3132